Medical device startup CardioMech announced this week that it has raised $13 million in new capital, bringing its total funding to $42 million. With the fresh funds, the company hopes to advance the ...

CardioMech received strong support by investors despite challenging environment because of its potential to be a category-defining Chordal Repair technology MINNEAPOLIS, Jan. 2, 2024 /PRNewswire/ -- ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min CardioMech is developing a heart ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. CardioMech's Series A round was led by an undisclosed ...

MINNEAPOLIS, June 24, 2026 /PRNewswire/ -- Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN ...

TRONDHEIM, Norway--(BUSINESS WIRE)--CardioMech AS announced today that it has appointed Richard Nehm as President and CEO, and Mark Novotny as Chairman of the Board of Directors, effective immediately ...

OSLO--(BUSINESS WIRE)--CardioMech AS announced today that it has closed on a convertible note financing of $2.5 million, which was significantly oversubscribed. The note included investments from ...

Mitral regurgitation, the backward flow of blood from the left ventricle into the left atrium, is the third most common cardiovascular disease in the United States, Rick Nehm, CEO of CardioMech, said ...

And a medical device startup company called CardioMech is growing operations in Minnesota to create implantable synthetic heartstrings to treat a complex heart condition called degenerative mitral ...

Medical device startup CardioMech raised $13 million to advance the development and validation of its flagship device, which is designed to treat degenerative mitral valve regurgitation. The ...

Ramin Mousavi, chief executive of Newport Beach-based CathWorks, has been appointed board chair of Norway-based medical device company CardioMech AS. CardioMech is developing a catheter-based repair ...